Biotechnology company Sanaria has announced the launch of a suite of products intended to advance research towards new malaria vaccines, drugs, and diagnostics, and enhanced understanding of malaria pathology and immunobiology. Sanaria’s mission is to develop and commercialize wholeparasite malaria vaccines that confer high-level, long-lasting protection against malaria caused by … [Read more...]